Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland

References

• GradmanAHBasileJNCarterBLBakrisGLAmerican Society of Hypertension Writing GroupCombination therapy in hypertensionJ Clin Hypertens (Greenwich)20111314615421366845
   PubMed Web of Science ®Google Scholar
• Danon-HerschNMarques-VidalPBovetPPrevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus studyEur J Cardiovasc Prev Rehabil200916667219188810
   PubMedGoogle Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J2013342159221923771844
   PubMed Web of Science ®Google Scholar
• de la SierraABarriosVBlood pressure control with angiotensin receptor blocker-based three-drug combinations: key trialsAdv Ther20122940141522610686
   PubMed Web of Science ®Google Scholar
• WaldDSLawMMorrisJKBestwickJPWaldNJCombination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trialsAm J Med200912229030019272490
   PubMed Web of Science ®Google Scholar
• Guidelines of the Swiss Society of Hypertension2009 Available from: http://www.swisshypertension.ch/guidelines.htmAccessed August 11, 2014
   Google Scholar
• ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA20032892560257212748199
   PubMed Web of Science ®Google Scholar
• GoASBaumanMAColeman KingSMAn effective approach to high blood pressure control: a science advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionHypertension20146387888524243703
   PubMed Web of Science ®Google Scholar
• BrixnerDIJacksonKC2ndShengXNelsonREKeskinaslanAAssessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinationsCurr Med Res Opin2008242597260718812017
   PubMed Web of Science ®Google Scholar
• BangaloreSShahaneAParkarSMesserliFHCompliance and fixed-dose combination therapyCurr Hypertens Rep2007918418917519122
   PubMed Web of Science ®Google Scholar
• GuptaAKArshadSPoulterNRCompliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysisHypertension20105539940720026768
   PubMed Web of Science ®Google Scholar
• BreitscheidelLEhlkenBKostevKOberdiekMSSandbergASchmiederREReal-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in GermanyJ Med Econ20121515516522035215
   PubMedGoogle Scholar
• SchaferHHScheunertUCosts of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary careSwiss Med Wkly2013143w1385424163048
   PubMedGoogle Scholar
• SchaferHHSudanoITheusGRNollGBurnierMTarget blood pressure attainment with antihypertensive therapy in Swiss primary careBlood Press20122121121922339442
   PubMed Web of Science ®Google Scholar
• FeldmanRDZouGYVandervoortMKWongCJNelsonSAFeaganBGA simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trialHypertension20095364665319237683
   PubMed Web of Science ®Google Scholar
• NeutelJMPrescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patientsCurr Med Res Opin2008242389240118616863
   PubMed Web of Science ®Google Scholar
• Bundesamt für Statistik (Hrsg.): Gesundheit und Gesundheitsverhalten in der Schweiz 2007 – Schweizerische GesundheitsbefragungBFS Neuchâtel2010
   Google Scholar
• ZygmuntowiczMOwczarekAElibolAChudekJComorbidities and the quality of life in hypertensive patientsPolskie Archiwum Medycyny Wewnetrznej201212233334022814517
   PubMed Web of Science ®Google Scholar
• BisognanoJDTownsendKASkylesAJSamuelsKMPrevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patientsAm J Geriatr Cardiol200716242917215639
   PubMed Web of Science ®Google Scholar
• BronsertMRHendersonWGValuckRHosokawaPHammermeisterKComparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) studyJ Am Board Fam Med20132652953824004705
   PubMed Web of Science ®Google Scholar
• ChobanianAVShattuck Lecture. The hypertension paradox – more uncontrolled disease despite improved therapyN Engl J Med200936187888719710486
   PubMed Web of Science ®Google Scholar
• SherrillBHalpernMKhanSZhangJPanjabiSSingle-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherenceJ Clin Hypertens (Greenwich)20111389890922142349
   PubMed Web of Science ®Google Scholar
• BaserOAndrewsLMWangLXieLComparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapyJ Med Econ20111457658321728914
   PubMedGoogle Scholar
• BelseyJDOptimizing adherence in hypertension: a comparison of outcomes and costs using single tablet regimens vs individual component regimensJ Med Econ20121589790522548677
   PubMedGoogle Scholar
• MyersMGPseudoresistant hypertension attributed to white-coat effectHypertension20125953253322252395
   PubMed Web of Science ®Google Scholar
• MyersMGGodwinMDawesMConventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trialBMJ2011342d28621300709
   PubMed Web of Science ®Google Scholar
• KjeldsenSEMesserliFHChiangCEMeredithPALiuLAre fixed-dose combination antihypertensives suitable as first-line therapy?Curr Med Res Opin2012281685169722978777
   PubMed Web of Science ®Google Scholar
• NeuhauserHThammMEllertUBlood pressure in Germany 2008–2011: results of the German Health Interview and Examination Survey for Adults (DEGS1)Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz20135679580123703500
   PubMed Web of Science ®Google Scholar
• OliverasASchmiederREClinical situations associated with difficult-to-control hypertensionJ Hypertens201331Suppl 1S3S823389084
   PubMed Web of Science ®Google Scholar
• OlivesCMyersonRMokdadAHMurrayCJLimSSPrevalence, awareness, treatment, and control of hypertension in United States counties, 2001–2009PLoS One20138e6030823577099
   PubMed Web of Science ®Google Scholar
• FlackJMCalhounDASatlinLBarbierMHilkertRBrunelPEfficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND studyJ Hum Hypertens20092347948919190658
   PubMed Web of Science ®Google Scholar
• KalraSKalraBAgrawalNCombination therapy in hypertension: an updateDiabetol Metab Syndr201024420576135
   PubMed Web of Science ®Google Scholar
• ManciaGSchumacherHRedonJBlood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)Circulation20111241727173621947289
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• JamersonKDevereuxRBakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med20083592417242819052124
   PubMed Web of Science ®Google Scholar
• SalvettiAGhiadoniLThiazide diuretics in the treatment of hypertension: an updateJ Am Soc Nephrol200617S25S2916565243
   PubMed Web of Science ®Google Scholar
• AldermanMHCohenHMadhavanSDiabetes and cardiovascular events in hypertensive patientsHypertension1999331130113410334799
   PubMed Web of Science ®Google Scholar